BRIDGEWATER, N.J., March 14, 2018 /PRNewswire/ -- Amneal Pharmaceuticals has received FDA approval for Erythromycin Tablets USP, 250 mg and 500 mg strengths. The Amneal product is a therapeutic ...
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as Zydus) has received final approval from the United States Food and Drug ...
Teva is offering generic erythromycin tablets in dosage strengths of 250 mg and 500 mg. It is indicated to treat a variety of bacterial infections, and to prevent initial or recurrent attacks of ...
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Erythromycin Tablets USP, available in strengths of 250 mg and 500 mg (USRLD: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results